Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences

test

00:00 / 00:00

Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences

Core acute presentations

Decision-Making Tree

Transcript

Watch video only

Premenstrual syndrome, or PMS and premenstrual dysphoric disorder, or PMDD are disorders that are characterized by cyclically occurring physical and affective symptoms that impair daily functioning. PMS is associated with symptoms such as irritability, mood swings, lethargy, and bloating, that occur during the luteal phase of the menstrual cycle, and resolve during or shortly after menstruation. On the other hand, PMDD is a type of depressive disorder characterized by severe and sometimes disabling changes in affect, like mood lability, irritability, dysphoria, and anxiety, that also occurs during the luteal phase and resolves with onset of menses. While the pathophysiology is not entirely understood, it’s likely multifactorial, and could be explained by an increased sensitivity to normal fluctuations in estrogen and progesterone levels that occur during the menstrual cycle.

Now, when a patient presents with a chief concern suggesting PMS or PMDD, your first step is to obtain a focused history and physical examination. Keep in mind that diagnosis of these premenstrual disorders is by exclusion, so before making your diagnosis, be sure to rule out other possible causes of your patient’s symptoms such as other mood disorders or medical conditions, such as thyroid disorders, anemia, depression, anxiety, and substance use. In addition, your patient should have experienced symptoms during most of their menstrual cycles over the past year, and ideally confirmed with at least two months of prospective monitoring with a symptom diary or calendar.

Okay, let’s start with PMS. Your patient will typically report symptoms that are cyclic in nature, because they typically follow their monthly cycle that begins with the luteal phase and ends with the onset of menstruation. Symptoms are both physical and affective, and include bloating, breast tenderness, irritability, mood swings, lethargy, anxiety and tension, and feelings of rejection. With these findings, you can diagnose PMS.

Treating PMS requires a blended, holistic approach that best meets the needs of your patient through shared decision-making, and should be based on individual goals of care. To start, offer education about the condition; and provide dietary counseling, including calcium supplementation, which is especially important in adolescent patients; and discuss the benefits of regular physical activity such as aerobic exercise, yoga, or Pilates. Also recommend cognitive behavioral therapy, which is beneficial in addressing symptoms through relaxation techniques, problem-solving skills, and stress management.

As far as pharmacotherapy goes, physical symptoms of PMS can be treated with over the counter non-steroidal anti-inflammatory drugs, or NSAIDs, such as ibuprofen. If moderate to severe affective symptoms are present, selective serotonin reuptake inhibitors, or SSRIs, such as sertraline, paroxetine, and fluoxetine can be used. For the treatment of overall symptoms, combined oral contraceptives, or COCs are typically used. These can be taken either cyclically starting with the luteal phase or taken continuously throughout their cycle.

Now, here’s a clinical pearl! COCs have added beneficial effects, such as reducing menstrual bleeding and cramping, and improving acne. Remember, though, that COCs are a form of contraception, so their use should be limited to those who desire protection against pregnancy. Additionally, while COCs can reduce symptom severity and functional impairment, they may not be effective in decreasing mood symptoms.

Okay, now let’s discuss PMDD. Like PMS, patients with PMDD will typically report a cyclic recurrence of symptoms beginning with the luteal phase and resolving with the onset of menses. In contrast to PMS, however, patients with PMDD report severe, sometimes disabling symptoms, which can have profound effects on daily function.

Sources

  1. "Management of premenstrual disorders: ACOG clinical practice guideline no 7" Obstet Gynecol (2023)
  2. "Menstrual disorders" Pediatr Rev (2013)
  3. "Diagnosis and treatment of premenstrual dysphoric disorder" Am Fam Physician (2002)
  4. "Nelson Textbook of Pediatrics, 21st ed. " Elsevier (2020)